Not a good buy right now: price is extended/overbought (RSI_6 ~87) and sitting just below near-term resistance (R1 ~29.80), which skews risk toward a pullback for an impatient entry.
Strong underlying business momentum (Q3 2025 YoY revenue +30.9%, net income +90.7%, EPS +81.8%) supports a bullish medium-term view, but the current technical setup is frothy.
Options positioning is strongly bullish (very low put/call), which often aligns with optimism—but at an overbought level it can also mean near-term upside is crowded.
If you must act immediately (impatient entry): this is closer to a “don’t chase” setup—best decision is to hold off rather than buy pre-market strength.
No analyst rating/price target change data was provided here, so recent Wall Street trend cannot be confirmed from this dataset.
Wall Street-style pros (based on provided fundamentals): accelerating revenue, strong EPS/net income growth, and expanding gross margin.
Wall Street-style cons (based on provided trading/technical context): entry timing is poor short-term due to overbought conditions and proximity to resistance; lack of near-term catalyst in recent news.
Influential trading check: hedge funds/insiders listed as Neutral (no significant recent trend); no recent congress trading data available.
Wall Street analysts forecast AROC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AROC is 32 USD with a low forecast of 30 USD and a high forecast of 35 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast AROC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AROC is 32 USD with a low forecast of 30 USD and a high forecast of 35 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 30.740
Low
30
Averages
32
High
35
Current: 30.740
Low
30
Averages
32
High
35
Wells Fargo
Overweight
initiated
$30
AI Analysis
2025-09-03
Reason
Wells Fargo
Price Target
$30
AI Analysis
2025-09-03
initiated
Overweight
Reason
Wells Fargo initiated coverage of Archrock with an Overweight rating and $30 price target. The firm says Archrock is a play on growing U.S. gas supply given its \"leading position\" in contract compression. The company is positioned to benefit from growing U.S. gas supply driven by liquified natural gas, rising artificial intelligence datacenter power demand, and onshoring of manufacturing, the analyst tells investors in a research note.
Mizuho
Gabriel Moreen
Outperform
maintain
$31 -> $32
2025-08-29
Reason
Mizuho
Gabriel Moreen
Price Target
$31 -> $32
2025-08-29
maintain
Outperform
Reason
Mizuho analyst Gabriel Moreen raised the firm's price target on Archrock to $32 from $31 and keeps an Outperform rating on the shares. The firm adjusted models in the master limited partnerships and midstream group post the Q2 reports.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AROC
